Citigroup’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$865M Sell
5,122,689
-119,999
-2% -$20.5M 0.37% 46
2025
Q4
$885M Buy
5,242,688
+1,521,992
+41% +$247M 0.39% 42
2025
Q3
$537M Sell
3,720,696
-353,271
-9% -$48.2M 0.24% 64
2025
Q2
$515M Buy
4,073,967
+865,823
+27% +$106M 0.25% 68
2025
Q1
$410M Buy
3,208,144
+1,351,276
+73% +$183M 0.21% 80
2024
Q4
$245M Sell
1,856,868
-122,732
-6% -$17.3M 0.15% 134
2024
Q3
$288M Sell
1,979,600
-1,109,021
-36% -$160M 0.17% 111
2024
Q2
$424M Buy
3,088,621
+502,072
+19% +$67M 0.27% 62
2024
Q1
$355M Buy
2,586,549
+375,201
+17% +$51.2M 0.23% 72
2023
Q4
$300M Sell
2,211,348
-117,729
-5% -$14.4M 0.21% 81
2023
Q3
$285M Sell
2,329,077
-25,805
-1% -$3.28M 0.21% 74
2023
Q2
$299M Buy
2,354,882
+354,350
+18% +$46M 0.2% 77
2023
Q1
$258M Buy
2,000,532
+306,853
+18% +$40.2M 0.18% 84
2022
Q4
$222M Buy
1,693,679
+127,581
+8% +$16.5M 0.18% 105
2022
Q3
$183M Sell
1,566,098
-495,616
-24% -$61.5M 0.13% 123
2022
Q2
$243M Buy
2,061,714
+88,129
+4% +$10.5M 0.18% 90
2022
Q1
$257M Buy
1,973,585
+376,498
+24% +$49M 0.16% 108
2021
Q4
$244M Buy
1,597,087
+754,549
+90% +$117M 0.13% 136
2021
Q3
$136M Sell
842,538
-973,636
-54% -$164M 0.08% 225
2021
Q2
$297M Sell
1,816,174
-369,742
-17% -$57M 0.18% 101
2021
Q1
$329M Buy
2,185,916
+420,459
+24% +$66.8M 0.21% 86
2020
Q4
$267M Buy
1,765,457
+399,267
+29% +$57.1M 0.16% 113
2020
Q3
$185M Buy
1,366,190
+83,138
+6% +$11.3M 0.12% 135
2020
Q2
$175M Sell
1,283,052
-881,005
-41% -$112M 0.14% 126
2020
Q1
$233M Sell
2,164,057
-3,059,726
-59% -$352M 0.21% 72
2019
Q4
$630M Buy
5,223,783
+1,380,564
+36% +$154M 0.46% 25
2019
Q3
$382M Buy
3,843,219
+2,361,619
+159% +$247M 0.3% 45
2019
Q2
$162M Sell
1,481,600
-477,345
-24% -$50.8M 0.13% 141
2019
Q1
$219M Buy
1,958,945
+739,469
+61% +$81.1M 0.21% 76
2018
Q4
$118M Sell
1,219,476
-1,319,247
-52% -$140M 0.12% 153
2018
Q3
$310M Sell
2,538,723
-169,647
-6% -$20M 0.28% 55
2018
Q2
$297M Buy
2,708,370
+588,358
+28% +$62.9M 0.27% 52
2018
Q1
$226M Buy
2,120,012
+120,191
+6% +$13.3M 0.19% 81
2017
Q4
$214M Buy
1,999,821
+537,657
+37% +$57.5M 0.17% 92
2017
Q3
$163M Sell
1,462,164
-2,527,653
-63% -$270M 0.13% 115
2017
Q2
$412M Sell
3,989,817
-357,210
-8% -$35.2M 0.37% 26
2017
Q1
$425M Buy
4,347,027
+637,176
+17% +$61M 0.38% 28
2016
Q4
$328M Sell
3,709,851
-2,792,430
-43% -$254M 0.3% 41
2016
Q3
$627M Buy
6,502,281
+3,260,706
+101% +$310M 0.59% 13
2016
Q2
$278M Sell
3,241,575
-1,830,465
-36% -$164M 0.28% 49
2016
Q1
$441M Buy
5,072,040
+1,515,363
+43% +$136M 0.5% 20
2015
Q4
$401M Sell
3,556,677
-2,058,720
-37% -$223M 0.4% 22
2015
Q3
$568M Buy
5,615,397
+738,186
+15% +$88.5M 0.53% 16
2015
Q2
$600M Buy
4,877,211
+455,718
+10% +$54.6M 0.53% 18
2015
Q1
$506M Buy
4,421,493
+1,139,880
+35% +$126M 0.49% 20
2014
Q4
$332M Sell
3,281,613
-3,110,613
-49% -$302M 0.3% 35
2014
Q3
$583M Buy
6,392,226
+1,352,094
+27% +$119M 0.51% 19
2014
Q2
$432M Sell
5,040,132
-2,926,236
-37% -$231M 0.41% 26
2014
Q1
$628M Buy
7,966,368
+2,741,046
+52% +$228M 0.64% 17
2013
Q4
$395M Buy
5,225,322
+2,269,038
+77% +$161M 0.36% 31
2013
Q3
$207M Sell
2,956,284
-146,550
-5% -$9.6M 0.19% 70
2013
Q2
$180M Buy
+3,102,834
New +$179M 0.18% 74

Other funds holding IBB